Ocular gets mixed FDA panel review for post-surgical sealant

09/20/2013 | MassDevice.com (Boston)

An FDA panel has voted in favor of recommending the safety of Ocular Therapeutix's ReSure Sealant, a topical hydrogel designed to temporarily close corneal incisions in patients who have undergone intraocular lens placement or cataract surgery. The panel, however, reached a split decision on the device's efficacy as well as on whether its benefits surpass the risks.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX